StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) PT Raised to $89 at Morgan Stanley
August 19, 2026 4:23 PM
Morgan Stanley analyst Terence Flynn raised the price target on Moderna (NASDAQ: MRNA) to $89.00 (from $39.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Morgan Stanley Upgrades Merck (MRK) to Overweight
August 19, 2026 4:22 PM
Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN
August 19, 2026 3:11 PM
BofA Securities Upgrades Moderna (MRNA) to Neutral
August 19, 2026 1:40 PM
Moderna short sellers face $4.8 billion loss amid record stock jump
August 19, 2026 11:31 AM
Moderna (MRNA) call put ratio 1 calls to 1.9 puts after INTerpath-001 trial results
August 19, 2026 11:21 AM
Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA) Following Positive Intismeran Data
August 19, 2026 9:34 AM
Stocks expected to have increasing option volume: MRNA RGEN DHR TMO MRVI SKHY
August 19, 2026 9:18 AM
